Verona Pharma plc (VRNA) Stock Chart - Revenue & Earnings | Quarter Chart

📊 Income Statement

Revenue by Product

ProductProduct and Service, Other
025M50M75M100M125M150M175M200MQ2 2024Q3 2024Q4 2024Q1 2025Q2 2025

Revenue by Geography

Revenue, Gross Profit, Operating and Net Income

RevenueGross ProfitOperating IncomeNet Income
025M50M75M100M125M150M175M200MQ2 2024Q3 2024Q4 2024Q1 2025Q2 2025

Margin (%)

Gross MarginOperating MarginNet Income Margin
0255075100125150175200Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025

Operating Expenses

Research And Development ExpensesSelling General And Administrative Expenses
010M20M30M40M50M60M70M80MQ2 2024Q3 2024Q4 2024Q1 2025Q2 2025

EBITDA

EBITDA
-70M-59M-48M-36M-25M-14M-2M9M20MQ2 2024Q3 2024Q4 2024Q1 2025Q2 2025

EPS

EPSEPS Diluted
000001111Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025

Revenue Variation (%)

Revenue Variation
088175262350438525612700Q4 2024Q1 2025Q2 2025

Income Variation (%)

Gross Profit VariationOperating Income VariationNet Income Variation
0100200300400500600700800Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025

Revenue YoY Variation (%)

Income YoY Variation (%)

Operating Income YoY VariationNet Income YoY Variation
02505007501K1K2K2K2KQ2 2024Q3 2024Q4 2024Q1 2025Q2 2025

Price-to-Earning Ratio

P/E Ratio
-200-138-75-1250112175238300Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025

Income Breakdown

Per Share Metrics

Operating IncomeInterest IncomeTotal Other Income Expenses NetNet Income
04M8M11M15M19M22M26M30MQ2 2024Q3 2024Q4 2024Q1 2025Q2 2025

Expense Ratios

Revenue Per ShareNet Income Per ShareOperating Cash Flow Per Share
000111222Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025
💰 Cash Flow Statement

Operating Cash Flow

Research And Ddevelopement To RevenueCapex To RevenueStock Based Compensation To Revenue
011223445Q2 2024Q3 2024Q4 2024Q1 2025Q2 2025

Free Cash Flow

Operating Cash FlowCapital ExpenditureFree Cash Flow
010M20M30M40M50M60M70M80MQ2 2024Q3 2024Q4 2024Q1 2025Q2 2025

Cash Flow to Debt Ratio

Cash At End Of Period
075M150M225M300M375M450M525M600MQ2 2024Q3 2024Q4 2024Q1 2025Q2 2025
🏦 Balance Sheet
📈 Key Metrics